2146 Results

People

  1. Aghajanian
    Aghajanian
  2. Hensley
    Hensley
  3. Abu-Rustum
    Abu-Rustum
  4. O'Cearbhaill
    O'Cearbhaill
  5. Makker
    Makker
  6. Tew
    Tew
  7. Lichtman
    Lichtman
  8. Zamarin
    Zamarin
  9. Chi
    Chi
  10. Iasonos
    Iasonos

Groups

  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)
  7. GDMT, Surgery (474)
  8. Epidemiology and Biostatistics (398)
  9. Department of Pathology and Laboratory Medicine (395)
  10. Survivorship Research (390)
  1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (1087)
  2. Meeting Abstract (890)
  3. Review (52)
  4. Book Section (46)
  5. Editorial (35)
  6. Guidelines (21)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)

More Groups

People
  1. Carol Aghajanian (607)
  2. Martee Hensley (289)
  3. Nadeem Abu-Rustum (288)
  4. Roisin O'Cearbhaill (271)
  5. Vicky Makker (263)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (41)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (450)
  2. Gynecologic Oncology (418)
  3. International Journal of Gynecological Cancer (154)
  4. Annals of Oncology (116)
  5. Clinical Cancer Research (67)
  6. Cancer Research (55)

More Publications

Publishers
  1. Elsevier Inc. (542)
  2. American Society of Clinical Oncology (489)
  3. Lippincott Williams & Wilkins (181)
  4. American Association for Cancer Research (168)
  5. Oxford University Press (143)
  6. Nature Publishing Group (86)

More Publishers

Results (2146)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Health-related quality of life (HRQoL) in advanced endometrial cancer (aEC) patients (pts) treated with lenvatinib plus pembrolizumab or treatment of physician's choice (TPC)
    Meeting Abstract

    Lorusso, D.; Colombo, N.; Herraez, A. C.; Santin, A.; Colomba, E.; Miller, D. S.; Fujiwara, K.; Pignata, S.; Baron-Hay, S. E.; Ray-Coquard, I. L.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • LIO-1: Lucitanib + nivolumab in patients with advanced solid tumors - Updated phase 1b results and initial experience in phase 2 ovarian cancer cohort
    Meeting Abstract

    Hamilton, E. P.; Jackson, C. C.; Eskander, R. N.; Backes, F. J.; Makker, V.; Musa, F.; Olawaiye, A.; Alldredge, J.; Pothuri, B.; Secord, A. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of zenocutuzumab in advanced pancreas cancer and other solid tumors harboring NRG1 fusions
    Meeting Abstract

    Schram, A. M.; O'Reilly, E. M.; O'Kane, G. M.; Goto, K.; Kim, D. W.; Neuzillet, C.; Martin-Romano, P.; Duruisseaux, M.; Nagasaka, M.; Rodon, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • ENGOT-ov60/GOG3052/RAMP 201: A phase 2 study of VS-6766 (dual RAF/MEK inhibitor) alone and in combination with defactinib (FAK inhibitor) in recurrent low-grade serous ovarian cancer (LGSOC)
    Meeting Abstract

    Banerjee, S. N.; Monk, B. J.; Van Nieuwenhuysen, E.; Moore, K. N.; Oaknin, A.; Fabbro, M.; Colombo, N.; O'Malley, D. M.; Coleman, R. L.; Pachter, J. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Safety and preliminary efficacy from the phase 1 portion of MasterKey-01: A First-in-human dose-escalation study to determine the recommended phase 2 dose (RP2D), pharmacokinetics (PK) and preliminary antitumor activity of BDTX-189, an inhibitor of allosteric ErbB mutations, in patients (pts) with advanced solid malignancies
    Meeting Abstract

    Schram, A. M.; Ahnert, J. R.; Patel, M. R.; Jauhari, S.; Sachdev, J. C.; Zhu, V. W.; LoRusso, P.; Nguyen, D.; Le, X.; O'Connor, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Olaparib treatment (Tx) in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSR OC) by BRCA mutation (BRCAm) and homologous recombination deficiency (HRD) status: Overall survival (OS) results from the phase II LIGHT study
    Meeting Abstract

    Mathews, C. A.; Simpkins, F.; Cadoo, K. A.; Liu, Y. L.; Provencher, D. M.; McCormick, C.; ElNaggar, A.; Altman, A. D.; Gilbert, L.; Black, D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinical pharmacokinetics of BDTX-189, an inhibitor of allosteric ErbB mutations, in patients with advanced solid malignancies in MasterKey-01 study
    Meeting Abstract

    Waters, N.; Patel, M. R.; Schram, A. M.; Ahnert, J. R.; Jauhari, S.; Sachdev, J. C.; Zhu, V. W.; LoRusso, P.; Nguyen, D.; Hong, D. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • MyPathway HER2 basket study: Pertuzumab (P) + trastuzumab (H) treatment of a large, tissue-agnostic cohort of patients with HER2-positive advanced solid tumors
    Meeting Abstract

    Meric-Bernstam, F.; Hainsworth, J.; Bose, R.; Burris, H. A. 3rd; Friedman, C. F.; Kurzrock, R.; Swanton, C.; Wang, Y.; Levy, J.; Schulze, K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • First-in-human study of highly selective FGFR2 inhibitor, RLY-4008, in patients with intrahepatic cholangiocarcinoma and other advanced solid tumors
    Meeting Abstract

    Schram, A. M.; Kamath, S. D.; El-Khoueiry, A. B.; Borad, M. J.; Mody, K.; Mahipal, A.; Goyal, L.; Sahai, V.; Schmidt-Kittler, O.; Shen, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Evaluating the role of aromatase inhibitors (AIs) in the treatment of endometrial stromal sarcomas (ESS)
    Meeting Abstract

    Crowley, F.; Cadoo, K. A.; Chiang, S.; Mueller, J. J.; Hensley, M. L.; O'Cearbhaill, R. E.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save